Showing results (1491-1500 of 1,593) with videos related to
Sort By:
Pageof 160
Journal of the American College of Cardiology|July 8, 2026
Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe RegistryConstantin-Cristian Topriceanu, Iswaree Devi Balakrishnan, Christoffer Rasmus Vissing, et al.Allergy|November 19, 2017
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines ProjectA Bonertz, G Roberts, J E Slater, et al.Rhinology|October 7, 2023
Consensus criteria for chronic rhinosinusitis disease control: an international Delphi StudyA R Sedaghat, W J Fokkens, V J Lund, et al.Journal of Medical Genetics|October 6, 2010
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancersK A Schrader, S Masciari, N Boyd, et al.The Journal of Biological Chemistry|May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionalityD Lee, S A Long, J L Adams, et al.Circulation|December 5, 2024
Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic CardiomyopathyJoshua K Meisner, Aaron Renberg, Eric D Smith, et al.Allergy|December 6, 2017
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergyG B Pajno, M Fernandez-Rivas, S Arasi, et al.Circulation|April 17, 2026
The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry AnalysisRobert Przybylski, Gabrielle Norrish, Brian Claggett, et al.The Lancet Regional Health. Europe|June 10, 2026
Assessing Europe's policy readiness to confront the MASLD/MASH public health threatJeffrey V Lazarus, Trenton M White, Leire Agirre-Garrido, et al.Allergy|July 28, 2017
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergyG J Sturm, E-M Varga, G Roberts, et al.Pageof 160